/KASE, June 24, 2025/ – The financial statements of Black Biotechnology LLP
(KASE ticker - BKBT) for 2024 and the auditor's report have been published.
According to the report of SFAI Kazakhstan LLP, the financial statements fairly
reflect in all material aspects the financial position of Black Biotechnology
LLP as of December 31, 2024, as well as its financial results and cash flows
for the year ended on that date, in accordance with International Financial
Reporting Standards (IFRS).
According to audited data as of December 31, 2024
(in thou. tenge, unless stated otherwise):
---------------------------------------------
as of as of
Indicator 12.31.24 12.31.23
------------------------- --------- ---------
Authorized capital 60,100 60,100
Equity (capital deficit) -117,386 7,583
Total assets 2,359,270 1,965,079
Total liabilities 2,476,656 1,957,496
Revenue 206,795 154,872
Gross profit (gross loss) 116,096 102,674
Net profit (net loss) -124,969 -13,668
ROA, % -5.30 -0.70
ROE, % 106.46 -180.25
ROS, % -60.43 -8.83
---------------------------------------------
Financial statements and report are published at
https://kase.kz/files/emitters/BKBT/bkbtf6_2024_rus.pdf
[2025-06-24]